Table 1. Determination of cytochrome P450 activity by electrochemical analysis of reaction products.
Enzyme |
Substrate |
Product |
Limit of detection, nM |
Vmax, min-1 |
KM, µМ |
Vmax/KM, min-1/µМ |
CYP2C9 |
(S)-Warfarin * |
(S)-7-Hydroxywarfarin |
91 |
0.100 ± 0.002 |
3.03 ± 0.38 |
0.033 |
CYP2C9 |
Diclofenac* |
4ʹ-Hydroxydiclofenac |
85 |
5.35 ± 0.13 |
11.66 ± 0.92 |
0.46 |
CYP2C9 |
(S)-Naproxene |
(S)-Desmethylnaproxen |
290 |
0.98 ± 0.03 |
331 ± 30 |
0.003 |
CYP2C19 |
Phenytoin |
4-Hydroxyphenytoin |
40 |
0.094 ± 0.002** |
25.8 ± 2.0** |
0.0036 |
CYP2E1 |
Chlorzoxazone* |
6-Hydroxychloroisoxazone |
110 |
1.64 ± 0.08 |
78 ± 9 |
0.021 |
CYP19A1 |
Androstenedione* |
Estrone |
11 |
51.6 ± 4.2 |
4.2 ± 1.5 |
12.29 |
CYP19A1 |
Testosterone* |
β-Estradiol |
3,4 |
10.2 ± 1.2 |
3.8 ± 1.3 |
2.68 |
Note: * marker substrate, ** Vmax и KM values are calculated for the high-affinity form of CYP2C19 according to the biphasic kinetics equation.